PILL241115C7000
- 0.00
- 0.000.00%
Direxion Daily Pharmaceutical & Medical Bull 3X Shares Newsroom
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Tuesday Market Finally Slows Down, Takes a Post Veterans Day Breather | Live Stock
Bristol-Myers Squibb Analyst Ratings
Triple Treat Monday Sees Indices Hit High Closes | Wall Street Today
What's Going On With Bristol-Myers Squibb Shares Monday?
How AbbVie Can Still Benefit From Cerevel Acquisition Despite Emraclidine Setback
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Market Opens to Fresh Highs | Live Stock
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
AbbVie Declines After Missing Main Goal in Schizophrenia Treatment Trials
Bristol Myers Squibb To Showcase Cardiovascular Breakthroughs At AHA, Including New CAMZYOS Data
14 Out of 18 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Insider Trades: Notable Buys and Sells by Significant Shareholders, Executives and Directors
Investors Elect to Accelerate Market on Election Week | Weekly Buzz
Friday Market Finished with Records | Wall Street Today
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Viatris Analyst Ratings